We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Novel Mutant Phospholipase D from Hemiscorpius lepturus Acts as A Highly Immunogen in BALB/c Mice Against the Lethality of Scorpion Venom.
- Authors
Soleimani Moez, Abouzar; H. Sajedi, Reza; Pooshang Bagheri, Kamran; Sabatier, Jean-Marc; Shahbazzadeh, Delavar
- Abstract
Hemiscorpius lepturus (H. lepturus) which belongs to the Scorpionidae family, is the deadliest scorpion in Iran. It causes pathological manifestations like dermonecrosis, hemolysis, renal failure, necrotic ulcers, and in some cases, even death. The venom of this scorpion is well-known for its cytotoxic effects in comparison with the other venomous scorpions which show significant neurotoxic effects. Due to the painless nature of the sting of this scorpion, the clinical symptoms occur in victims 24 to 72 h post-sting. In our previous studies during the last decade, we demonstrated that the medical complications are attributable to the presence of phospholipase D (PLD) as a major toxin in the venom. With the purpose of designing and constructing a vaccine against H. lepturus for humans, animal model experiments were performed. To achieve this goal, non-toxic PLD was developed by mutation of two critical catalytic residues—His12 and His48—into alanines and the product was then denominated mut-rPLD1. The in-vivo tests showed that the mice immunized with interval doses of 10 µg of mut-rPLD1, were completely protected against 10× the LD100 of the venom. In conclusion, this mutant may be an effective vaccine candidate against scorpion envenomation by H. lepturus in future clinical studies.
- Subjects
IRAN; PHOSPHOLIPASE D; BIBLE. Acts; SCORPION venom; KIDNEY failure; SCORPIONS; PHOSPHOLIPASES; ANIMAL experimentation; MICE
- Publication
Molecules, 2020, Vol 25, Issue 7, p1673
- ISSN
1420-3049
- Publication type
Article
- DOI
10.3390/molecules25071673